Comprehensive Bioinformatics Analyses and Experimental Validation of the Cell Cycle Related Protein SAPCD2 as a New Biomarker and Potential Therapeutic Target in Pancreatic Cancer
SAPCD2 serves as both a prognostic marker and a potential therapeutic target in PAAD, where its low expression may enhance responsiveness to specific drugs. These findings underscore SAPCD2's dual role in cancer progression and therapy.
Authors
- Jian Qi (ORCID: https://orcid.org/0000-0003-2276-2519)
- Xiuji Huang (ORCID: https://orcid.org/0000-0002-8969-1279)
- Lingling Ke (ORCID: https://orcid.org/0000-0002-5546-1643)
- Tingting Luo
- Yuting Liu (ORCID: https://orcid.org/0009-0002-9875-0741)
- Yuchen Liu (ORCID: https://orcid.org/0000-0002-6517-0022)
- Bo Li (ORCID: https://orcid.org/0000-0002-4456-7303)
- Jiahui Lin (ORCID: https://orcid.org/0009-0006-7334-640X)
- Liangliang Xu (ORCID: https://orcid.org/0000-0002-3900-9972)
- Yu Deng (ORCID: https://orcid.org/0009-0007-8220-3651)
- Huixian Wu (ORCID: https://orcid.org/0009-0003-9112-3224)
Institutions
- Sun Yat-sen University (CN)
- University of Macau (MO)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Peking University Shenzhen Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jir.s501850
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05